Background: Patients with end stage renal disease (ESRD) are at significantly increased risk for both thrombosis and bleeding relative to those with normal renal function, which makes anticoagulation particularly challenging. Evidence suggests that rivaroxaban and dabigatran are associated with a higher risk of bleeding in ESRD patients. To date, no large national cohort studies have […]

Case Presentation: A 35-year-old woman with a history of congenital renal dysplasia complicated by end stage renal disease (ESRD) on hemodialysis, chronic macrocytic anemia, and malnutrition with folate, vitamins B12 and A deficiencies, presented with fatigue, dyspnea, and new rash. One week prior to presentation, the patient started experiencing progressive dyspnea on exertion. At her […]

Case Presentation: A 41 year-old female with a history significant for end stage renal disease (ESRD) secondary to focal segmental glomerulosclerosis (FSGS) on peritoneal dialysis for two years, uremic pericardial effusion with pericardiocentesis three years prior, and polyarticular gout on allopurinol presented as a transfer from an outside hospital for evaluation due to concerns for […]

Case Presentation: A 42-year-old female with a past medical history of end stage renal disease from focal segmental glomerulosclerosis on hemodialysis for the past four years, presented to her cardiologist with worsening dyspnea on exertion and a feeling of “increased fluid in her lungs”. An outpatient transthoracic echocardiogram (TTE) was obtained, which showed a normal […]